{"id":13203,"date":"2026-03-24T02:55:13","date_gmt":"2026-03-24T01:55:13","guid":{"rendered":"https:\/\/glutenlight.eu\/?p=13203"},"modified":"2026-03-24T02:56:18","modified_gmt":"2026-03-24T01:56:18","slug":"gluten-peptides-relatively-resistant-to-digestion-interactions-with-the-intestinal-barrier-innate-immunity-and-mucosal-vulnerability","status":"publish","type":"post","link":"https:\/\/glutenlight.eu\/?p=13203&lang=en","title":{"rendered":"Gluten peptides relatively resistant to digestion: interactions with the intestinal barrier, innate immunity, and mucosal vulnerability"},"content":{"rendered":"

The present text summarizes some mechanistic evidence regarding the interaction between protein fragments relatively resistant to digestion, the intestinal barrier, and mucosal immunity.<\/span><\/p>\n

1. General framework<\/b><\/span><\/p>\n

The digestion of dietary proteins generates peptide fragments that are normally further degraded and handled by the mucosal immune system without causing pathological effects.<\/span><\/p>\n

Under physiological conditions, the intestinal barrier, immune tolerance mechanisms, and the action of the microbiota contribute to maintaining a functional balance between dietary antigen exposure and the body\u2019s response.<\/span><\/p>\n

When these systems are altered or particularly sensitive, some peptides relatively resistant to digestion may interact more actively with the immunological environment of the intestinal mucosa.<\/span><\/p>\n

2. Resistant peptides and innate immunity<\/b><\/span><\/p>\n

Some protein fragments derived from gluten have structural characteristics that slow their complete enzymatic hydrolysis. Experimental studies (in vitro and in vivo in murine models) have shown that these fragments may:<\/span><\/p>\n

a – activate innate signaling pathways (e.g. MyD88-dependent pathways)<\/span><\/p>\n

b – modulate the production of local inflammatory mediators<\/span><\/p>\n

c – interact with the intestinal epithelium by influencing tight junction organization<\/span><\/p>\n

d – in specific models, activate the NLRP3 inflammasome<\/span><\/p>\n

It is important to emphasize that these observations derive mainly from controlled experimental models; however, they demonstrate the biological plausibility of an interaction between persistent protein fragments and mucosal immunity.<\/span><\/p>\n

3. Intestinal permeability and functional vulnerability<\/b><\/span><\/p>\n

The intestinal barrier represents a dynamic system regulated by:<\/span><\/p>\n

1 – tight junctions<\/span><\/p>\n

2 – mucus and microbiota<\/span><\/p>\n

3 – local immune signals<\/span><\/p>\n

In conditions of vulnerability \u2014 such as:<\/span><\/p>\n

1 – irritable bowel syndrome<\/span><\/p>\n

2 – chronic dysbiosis<\/span><\/p>\n

3 – prolonged stress<\/span><\/p>\n

4 – metabolic obesity<\/span><\/p>\n

5 – non-intestinal inflammatory conditions associated with increased permeability<\/span><\/p>\n

the epithelial response threshold may be altered.<\/span><\/p>\n

In such contexts, the presence of protein fragments relatively resistant to digestion may:<\/span><\/p>\n

1 – prolong mucosal contact<\/span><\/p>\n

2 – promote local activation of innate immunity<\/span><\/p>\n

3 – contribute to a low-grade pro-inflammatory environment<\/span><\/p>\n

This is not a matter of direct causality demonstrated in healthy humans, but of plausible interactions in predisposing conditions.<\/span><\/p>\n

4. Microbiota as a response modulator<\/b><\/span><\/p>\n

The intestinal microbiota plays a central role in the handling of dietary proteins:<\/span><\/p>\n

it participates in the secondary degradation of peptides<\/span><\/p>\n

it modulates barrier integrity<\/span><\/p>\n

it influences the local immune profile<\/span><\/p>\n

Animal models have shown that microbial composition can amplify or attenuate the mucosal response to wheat protein components.<\/span><\/p>\n

In humans, dietary studies show that changes in gluten intake are associated with variations in the microbiota; however, these effects are often intertwined with changes in fiber and the overall food matrix.<\/span><\/p>\n

In subjects with dysbiosis or unstable microbial balance, the handling of persistent protein fragments may be less efficient.<\/span><\/p>\n

5. Clinical conditions not always overt<\/b><\/span><\/p>\n

Some individuals present with:<\/span><\/p>\n

fluctuating gastrointestinal symptoms<\/span><\/p>\n

unexplained chronic fatigue<\/span><\/p>\n

mild metabolic alterations<\/span><\/p>\n

functional intestinal disorders<\/span><\/p>\n

In these cases, even in the absence of a structured diagnosis, there are sometimes observed:<\/span><\/p>\n

markers of altered barrier function<\/span><\/p>\n

increased low-grade pro-inflammatory cytokines<\/span><\/p>\n

modifications of the microbiota<\/span><\/p>\n

There is no robust clinical evidence demonstrating that gluten peptides are the direct cause of such conditions; however, in the presence of vulnerability, the quality of protein digestion and the burden of persistent fragments may represent a modulating factor.<\/span><\/p>\n

6. Individual vulnerability, fermentation, and modulation of the persistent peptide load<\/b><\/span><\/p>\n

The relationship between foods and the organism is never linear, but systemic.<\/span><\/p>\n

The response to a dietary protein does not depend exclusively on its composition, but rather on the dynamic interaction among:<\/span><\/p>\n

1 – the functional state of the intestinal barrier<\/span><\/p>\n

2 – the microbiota profile<\/span><\/p>\n

3 – the regulation of innate immunity<\/span><\/p>\n

4 – the efficiency of digestive processes<\/span><\/p>\n

5 – the individual metabolic and inflammatory context<\/span><\/p>\n

In a fully healthy subject, these systems cooperate effectively in ensuring the complete handling of the protein fragments deriving from gluten digestion.<\/span><\/p>\n

The possible presence of peptides relatively resistant to digestion does not, in itself, entail a clinically relevant disturbance.<\/span><\/p>\n

Conversely, in the presence of vulnerabilities \u2014 genetic, immunological, metabolic, or functional \u2014 even mild alterations of the barrier or microbiota may modify the organism\u2019s response threshold.<\/span><\/p>\n

Within this framework, fermentation technology takes on relevance that goes beyond the sensory or structural aspect of the product.<\/span><\/p>\n

Prolonged fermentation, controlled acidification, and microbial peptidase activity may:<\/span><\/p>\n

1 – reduce the average molecular weight of protein fractions<\/span><\/p>\n

2 – modify the peptide profile of the dough<\/span><\/p>\n

3 – decrease the proportion of relatively persistent fragments<\/span><\/p>\n

4 – make the protein matrix more accessible to enzymatic digestion<\/span><\/p>\n

7. Summary of the evidence<\/b><\/span><\/p>\n

In healthy subjects, the organism effectively regulates the response to dietary protein fragments.<\/span><\/p>\n

In the presence of immunological vulnerability, non-specific genetic predisposition, or alterations of the mucosal barrier, the response to relatively digestion-resistant peptides may be statistically amplified.<\/span><\/p>\n

The strongest evidence derives from experimental models; clinical data in humans remain limited.<\/span><\/p>\n

The intestinal microbiota represents a key mediator in the modulation of these effects.<\/span><\/p>\n

8. Prudential implication<\/b><\/span><\/p>\n

In subjects with predisposing conditions \u2014 even if not fully manifest \u2014 a prudent nutritional approach may be justified.<\/span><\/p>\n

Such an approach should be:<\/span><\/p>\n

1 – personalized<\/span><\/p>\n

2 – contextualized<\/span><\/p>\n

3 – integrated into the overall assessment of health status<\/span><\/p>\n

and not intended as a generalization applicable to the healthy population.<\/span><\/p>\n

Bibliography<\/b><\/span><\/p>\n

Scientific studies connected to the most relevant passages of the systemic concluding paragraph: interaction of digestion-resistant protein fragments with the intestinal barrier, innate immune signals, and modulation of the microbiota.<\/span><\/p>\n

1. Intestinal barrier (paracellular opening mechanism)<\/b><\/span><\/p>\n

Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3 \u2014 Alessio Fasano et al., 2008, Gastroenterology<\/span><\/p>\n

Why it is central<\/span><\/p>\n

This study demonstrates the molecular mechanism by which gliadin components can modulate the intestinal barrier.<\/span><\/p>\n

Mechanism shown<\/span><\/p>\n

gliadin \u2192 CXCR3 \u2192 MyD88 \u2192 zonulin release \u2192 tight junction opening<\/span><\/p>\n

Why it is fundamental<\/span><\/p>\n

it directly links dietary peptides \u2192 intestinal permeability<\/span><\/p>\n

it identifies the receptor and the signaling pathway<\/span><\/p>\n

it is one of the most cited studies on barrier modulation.<\/span><\/p>\n

Role in your article<\/span><\/p>\n

It is the foundation for the mucosal barrier \/ gatekeeping chapter.<\/span><\/p>\n

2. Activation of innate immunity<\/b><\/span><\/p>\n

Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent \u2014 Steven N. Vogel et al., 2006, The Journal of Immunology<\/span><\/p>\n

Why it is central<\/span><\/p>\n

It demonstrates that gliadin and resistant peptides can activate innate immunity.<\/span><\/p>\n

Mechanism shown<\/span><\/p>\n

gliadin peptides \u2192 MyD88-dependent activation \u2192<\/span><\/p>\n

expression of inflammatory genes in macrophages + modulation of intestinal permeability.<\/span><\/p>\n

Why it is important<\/span><\/p>\n

it explains that the effect is not only on the barrier, but also on immune signaling<\/span><\/p>\n

it directly links resistant peptides \u2192 innate immune response<\/span><\/p>\n

Role in your article<\/span><\/p>\n

It is the basis for the section on resistant peptides as innate immunological signals.<\/span><\/p>\n

3. Inflammasome and mucosal damage<\/b><\/span><\/p>\n

p31-43 Gliadin Peptide Forms Oligomers and Induces NLRP3 Inflammasome\/Caspase-1-Dependent Mucosal Damage in Small Intestine \u2014 Fernando G. Chirdo et al., 2019, Frontiers in Immunology.<\/span><\/p>\n

Why it is central
\nIt shows that a single resistant peptide (p31-43) can activate the NLRP3 inflammasome in vivo.
\nMechanism shown
\np31-43 \u2192 oligomerization \u2192 activation of the NLRP3 inflammasome \u2192
\ncaspase-1 \u2192 IL-1\u03b2 \u2192 mucosal damage
\nWhy it is very strong
\nit demonstrates a complete inflammatory mechanism
\nit occurs in vivo in the animal model
\nit links peptide persistence \u2192 structured inflammatory response
\nRole in your article
\nIt is the basis of the section on activation of mucosal inflammation.
\nWhy these three form the mechanistic axis
\nTogether they describe a coherent biological sequence:
\n1\ufe0f\u20e3 Resistant peptides \u2192 intestinal barrier
\n(Lammers)
\n2\ufe0f\u20e3 Resistant peptides \u2192 innate immunity
\n(Thomas)
\n3\ufe0f\u20e3 Resistant peptides \u2192 inflammasome and mucosal damage
\n(G\u00f3mez Castro)
\nThey therefore explain:
\ndietary peptide \u2192 barrier \u2192 immunity \u2192 inflammation<\/p>\n

B. Research, studies related to the chapters<\/b><\/span><\/p>\n

1. Intestinal barrier and permeability<\/span><\/h1>\n

1.1 Gliadin \u2192 CXCR3 \u2192 MyD88 \u2192 zonulin \u2192 \u2191 permeability (murine ex vivo + human expression data)<\/span><\/h2>\n

Lammers KM et al. (2008)
\nTitle: Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3
\nJournal: Gastroenterology
\nDOI: 10.1053\/j.gastro.2008.03.023 (PubMed)
\nModel \/ what it measures
\nMurine small intestine ex vivo (intestinal segments) + permeability testing and zonulin release
\nReceptor validation: CXCR3 and MyD88 involvement
\nKey results
\nGliadin (and some overlapping peptides) binds to CXCR3 and induces CXCR3\u2013MyD88 association in the epithelium. (PubMed)
\nIt increases zonulin release and permeability in wild-type; the effect is absent in CXCR3\u2212\/\u2212. (PubMed)
\nHow to translate it into the chapter
\nIt is one of the \u201ccleanest\u201d demonstrations that gluten components can act as functional modulators of the barrier (paracellular opening) through innate pathways.<\/p>\n

1.2. Barrier effect on human tissue ex vivo (TEER and permeability)
\nHollon J et al. (2015)
\nTitle: Effect of gliadin on permeability of intestinal biopsy explants from celiac disease patients and patients with non-celiac gluten sensitivity
\nJournal: Nutrients
\nDOI: 10.3390\/nu7031565 (PubMed)
\nModel \/ what it measures
\nHuman intestinal biopsies ex vivo in chamber (microsnapwell)
\nTEER measurement (transepithelial electrical resistance) as a proxy for barrier integrity
\nKey results (mechanistic)
\nExposure to gliadin \u2192 worsening of barrier indices (\u2193 TEER \/ \u2191 permeability) in the experimental set-up. (PubMed)
\nManual-style use
\nUseful because it shifts the issue from murine biology alone to a measurable effect on human tissue, while still remaining an ex vivo model (therefore not \u201cclinical\u201d).<\/p>\n

2. Innate immune activation by resistant peptides<\/span><\/h1>\n

2.1 Innate immunity: response to resistant peptides (MyD88, interferons, inflammasome)
\nGliadin + \u201cresistant\u201d peptides \u2192 permeability + macrophage activation (MyD88-dependent)
\nThomas KE et al. (2006)
\nTitle: Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent
\nJournal: The The Journal of Immunology
\nDOI: 10.4049\/jimmunol.176.4.2512 (PubMed)
\nModel \/ what it measures
\nMurine macrophages + expression of inflammatory genes\/cytokines
\nIntestinal permeability testing and zonulin release in the experimental system
\nStimuli: gliadin and peptides (including 33-mer and p31\u201343)
\nKey results
\nGliadin and derivatives (33-mer, p31\u201343) induce:
\nincreased permeability (via zonulin)
\nup-regulation of inflammatory signals in macrophages
\nin a MyD88-dependent manner. (OUP Academic)
\nMessage for the manual
\nResistant peptides can be viewed as \u201csignals\u201d capable of activating innate immunity and modulating the barrier, independently of the clinical discussion on celiac disease.<\/p>\n

2.2. p31\u201343 in vivo: MyD88 and type I interferons (mouse)
\nAraya RE et al. (2016)
\nTitle: Mechanisms of innate immune activation by gluten peptide p31-43 in mice
\nJournal: Am J Physiol Gastrointest Liver Physiol
\nDOI: 10.1152\/ajpgi.00435.2015 (PubMed)
\nModel \/ what it measures
\nIntraluminal administration of p31\u201343 in mice
\nAnalysis: mucosal damage, cell death, inflammatory mediators
\nKey results
\np31\u201343 induces mucosal alterations and inflammatory mediators; dependence on MyD88 and type I IFN, not on TLR4 in the set-up. (PubMed)
\nWhy it is needed
\nIt is a strong step: a single resistant peptide can activate innate circuits in vivo.<\/p>\n

2.3. p31\u201343: oligomerization \u2192 NLRP3 inflammasome\/caspase-1 \u2192 mucosal damage (mouse)
\nG\u00f3mez Castro MF et al. (2019)
\nTitle: p31-43 Gliadin Peptide Forms Oligomers and Induces NLRP3 Inflammasome\/Caspase 1-Dependent Mucosal Damage in Small Intestine
\nJournal: Frontiers in Immunology
\nDOI: 10.3389\/fimmu.2019.00031 (Frontiers)
\nModel \/ what it measures
\np31\u201343 administered to mice + histology, IFN\u03b2, mature IL-1\u03b2
\nKO\/inhibition experiments for NLRP3 and caspase-1
\nPhysicochemical study: tendency of the peptide to form oligomers
\nKey results
\nThe induced enteropathy is not observed without NLRP3 or caspase-1, and is reduced with a caspase-1 inhibitor. (PubMed)
\nThe peptide shows a propensity for self-assembly\/aggregation, linked to inflammasome activation. (Frontiers)
\nTake-home
\n\u201cDigestive resistance\u201d is not only chemical: it may favor persistence\/aggregation and activate innate platforms (inflammasome).<\/p>\n

2.4. Intracellular persistence and epithelial stress (cells + mucosa)
\nLuciani A et al. (2010)
\nTitle: Lysosomal accumulation of gliadin p31-43 peptide induces oxidative stress\u2026
\nJournal: Gut
\nDOI: 10.1136\/gut.2009.183608 (PubMed)
\nKey results
\np31\u201343 can accumulate in lysosomal compartments and induce oxidative stress and cellular responses in epithelial and mucosal models. (PubMed)
\nUtility
\nIt adds the \u201ccellular\u201d level: resistant peptides may also act through stress\/intracellular trafficking, not only through tight junctions.<\/p>\n

3. Microbiota and host response modulation<\/span><\/h1>\n

3.1. Human data: microbiota, symptoms, and biomarkers (with the fiber caveat)<\/span><\/h3>\n

Diet context: microbiota, barrier, and immune interactions<\/span><\/strong><\/p>\n

Human dietary studies investigating gluten intake rarely isolate gluten itself. Changes in gluten consumption are usually accompanied by modifications in cereal composition, fiber intake, and overall dietary matrix.<\/p>\n

What these studies measure<\/strong><\/p>\n

Human intervention or observational studies typically evaluate:<\/p>\n

    \n
  • \n

    intestinal microbiota composition<\/p>\n<\/li>\n

  • \n

    microbial metabolic activity (e.g., fermentation markers)<\/p>\n<\/li>\n

  • \n

    gastrointestinal symptoms<\/p>\n<\/li>\n

  • \n

    selected metabolic or inflammatory biomarkers<\/p>\n<\/li>\n<\/ul>\n

    Interpretative limitation<\/strong><\/p>\n

    A major confounding factor in these studies is that reducing gluten intake often simultaneously modifies:<\/p>\n

      \n
    • \n

      total dietary fiber<\/p>\n<\/li>\n

    • \n

      fermentable carbohydrate composition<\/p>\n<\/li>\n

    • \n

      cereal matrix structure<\/p>\n<\/li>\n<\/ul>\n

      Therefore, observed microbiota changes cannot always be attributed to gluten itself.<\/p>\n

      Relevance for the present discussion<\/strong><\/p>\n

      These studies are useful because they translate mechanistic hypotheses into real human physiology. However, they must be interpreted cautiously, as microbiota changes often reflect broader dietary shifts rather than the isolated biological effect of gluten-derived peptides.<\/p>\n

      3.2. Gliadin in the diet (HFD) \u2192 microbiota + barrier + immune phenotypes (mice)
      \nZhang L et al. (2017)
      \nTitle: Effects of Gliadin consumption on the Intestinal Microbiota and Metabolic Homeostasis in Mice Fed a High-fat Diet
      \nJournal: Scientific Reports
      \nDOI: 10.1038\/srep44613 (PubMed)
      \nModel \/ what it measures
      \nHFD with vs without 4% gliadin for 23 weeks
      \n\u201cIntegrated\u201d analysis: microbiota in 3 compartments, barrier function, urinary metabolome, immune profiles in multiple tissues
      \nKey results
      \nGliadin is associated with changes in microbiota composition\/activity, barrier function, and immune phenotypes (in addition to metabolic parameters) in the HFD context. (PubMed)
      \nInterpretative note (important)
      \nIt is a \u201cstressed\u201d model (HFD): useful for discussing aggravating factors, not for generalizing to bread\/pizza \u201cunder ideal conditions.\u201d<\/p>\n

      3.3. Gluten and barrier function in an inflammatory context: DSS colitis + diet with gluten (mice)
      \nMenta\/Alvarez-Leite et al. (2019)
      \nTitle: Wheat gluten intake increases the severity of experimental colitis and bacterial translocation by weakening of the proteins of the junctional complex
      \nJournal: British Journal of Nutrition
      \nDOI: 10.1017\/S0007114518003422 (PubMed)
      \nModel \/ what it measures
      \nDSS-colitis + standard diet vs diet with ~4.5% wheat gluten
      \nOutcome: colitis severity, permeability, bacterial translocation, proteins of the junctional complex
      \nKey results
      \nDietary gluten worsens the picture in the presence of colitis, with increased permeability and bacterial translocation, and alterations of junctional proteins\/organization. (PubMed)
      \nUse in the manual
      \nIt is a strong example of \u201cresistant peptides as an aggravating factor in an already compromised intestine,\u201d without saying they are the primary cause.<\/p>\n

      4. Human dietary studies<\/b><\/span><\/h1>\n

      4.1 Human data: microbiota, symptoms, and biomarkers (with the fiber caveat)<\/h3>\n

      Here, more than \u201cpeptides\u201d in the strict sense, the studies test gluten intake (or its reduction) and measure microbiota, intestinal fermentation, and symptoms. They are useful because they translate the discussion into real human physiology; however, they present a major confounding factor: changes in gluten intake are usually accompanied by changes in dietary fiber and cereal matrix composition.<\/p>\n

      4.2 Randomized crossover trial: low-gluten vs high-gluten (60 non-celiac adults)<\/h3>\n

      Hansen LBS \/ Roager HM \/ Licht TR et al. (2018)<\/strong>
      \nTitle:<\/strong> A low-gluten diet induces changes in the intestinal microbiome of healthy Danish adults
      \nJournal:<\/strong> Nature Communications
      \nDOI:<\/strong> 10.1038\/s41467-018-07019-x<\/p>\n

      What it measures<\/strong><\/p>\n

        \n
      • \n

        Shotgun metagenomics<\/p>\n<\/li>\n

      • \n

        intestinal fermentation (H\u2082 breath test)<\/p>\n<\/li>\n

      • \n

        gastrointestinal symptoms (bloating)<\/p>\n<\/li>\n

      • \n

        selected metabolic and inflammatory biomarkers<\/p>\n<\/li>\n<\/ul>\n

        Key results<\/strong><\/p>\n

        Low-gluten diet \u2192 moderate changes in the intestinal microbiome and reduced hydrogen production, accompanied by improvement in reported bloating.<\/p>\n

        The authors emphasize that these effects are likely driven largely by changes in dietary fiber composition rather than gluten itself<\/strong>.<\/p>\n

        No major changes were observed in systemic inflammatory markers; interpretation therefore remains cautious.<\/p>\n

        How to use it<\/strong><\/p>\n

        This study supports the idea that physiological responses depend on the overall food matrix and dietary composition<\/strong>, not on isolated gluten alone.<\/p>\n

        4.3. Short intervention: 4 weeks of GFD in healthy volunteers (21 subjects)
        \nBonder MJ et al. (2016)
        \nTitle: The influence of a short-term gluten-free diet on the human gut microbiome
        \nJournal: Genome Medicine
        \nDOI: 10.1186\/s13073-016-0295-y (SpringerLink)
        \nKey results
        \nModerate taxonomic changes; more evident effects on predicted microbial pathways (many linked to carbohydrate\/starch metabolism). (SpringerLink)
        \nSelected intestinal\/inflammatory biomarkers: no major \u201cclinical\u201d signal in healthy subjects in the short term (cautious interpretation). (SpringerLink)<\/p>\n

        Pathophysiological conclusion<\/b><\/span>
        \nOverall, the experimental evidence indicates that some gluten components and specific peptides relatively resistant to digestion can interact with intestinal physiology at multiple levels.
        \nAt the level of the mucosal barrier, these fragments may modulate paracellular permeability through innate signaling pathways, involving mediators such as CXCR3, MyD88, and zonulin.
        \nAt the immune level, some resistant peptides \u2014 particularly p31-43 in experimental models \u2014 are able to activate local innate responses, including interferon-dependent pathways and, under certain conditions, the NLRP3\/caspase-1 inflammasome.
        \nAt the ecological and functional level, the microbiota appears both as a modulator of the host response to gluten and as a possible target of the effects induced by the dietary context in which gluten itself is consumed.
        \nIn human studies, the observed effects mainly concern moderate modifications of the microbiota and intestinal fermentation; however, these data must be interpreted with caution, since they often reflect concomitant variations in dietary fiber and the overall matrix of the diet, rather than the isolated action of gluten.<\/p>\n

        Concluding methodological note<\/b>
        \nThese studies do not state that gluten protein fragments are in themselves pathological in the healthy subject. However, they provide biologically plausible mechanisms for how:
        \nspecific resistant protein sequences (e.g. from gluten) can activate cellular signals in the intestinal epithelium and innate immunity, (PubMed)
        \nthis activation can include changes in paracellular permeability and pro-inflammatory pathways (inflammasome), (PubMed)
        \nthe way the organism responds to these signals is influenced by individual factors (microbiota, mucosal barrier, immunological vulnerability). (PubMed)
        \nThese studies are predominantly:
        \nmodel-based (in vitro \/ ex vivo)
        \nin vivo in animals
        \nbased on synthetic protein fragments or fragments administered in a non-physiological manner
        \nThat is, they are not clinical studies in humans under normal dietary conditions, but rather mechanistic evidence on biological pathways that could be relevant in the context of subjects with a fragile intestinal barrier, altered microbiota, or subclinical immunological vulnerability.<\/p>\n

        \n","protected":false},"excerpt":{"rendered":"

        The present text summarizes some mechanistic evidence regarding the interaction between protein fragments relatively resistant to digestion, the intestinal barrier, and mucosal immunity. 1. General framework The digestion of dietary proteins generates peptide fragments that are normally further degraded and handled by the mucosal immune system without causing pathological effects. Under physiological conditions, the intestinal […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[73],"tags":[3251,3213,3247,3235,3219,3201,3255,3205,3245,3199,3233,3203,3207,3229,3215,3231,3243,3217,3241,3237,3209,3223,3225,3227,3221,3239,3249,3257,3253,3211],"class_list":["post-13203","post","type-post","status-publish","format-standard","hentry","category-article","tag-breadmaking-and-protein-digestion","tag-cxcr3-myd88-zonulin-pathway","tag-dough-fermentation-and-gluten-digestion","tag-food-peptides-and-innate-immunity","tag-gliadin-p31-43-inflammasome-activation","tag-gliadin-peptide-p31-43","tag-gluten-biochemistry","tag-gluten-intestinal-permeability","tag-gluten-microbiota-interaction","tag-gluten-peptides-resistant-to-digestion","tag-gut-brain-axis-inflammation","tag-incomplete-gluten-digestion","tag-intestinal-barrier-and-gluten","tag-intestinal-dysbiosis-and-gluten","tag-intestinal-innate-immunity","tag-intestinal-mucosal-barrier","tag-intestinal-mucosal-vulnerability","tag-intestinal-nlrp3-inflammasome","tag-intestinal-permeability-and-inflammation","tag-intestinal-protein-digestion","tag-intestinal-tight-junctions","tag-low-grade-intestinal-inflammation","tag-microbiota-and-gluten","tag-microbiota-and-protein-digestion","tag-mucosal-immune-activation","tag-mucosal-immune-response","tag-natural-fermentation-and-peptide-degradation","tag-nutritional-intestinal-immunology","tag-wheat-protein-matrix","tag-zonulin-and-gluten"],"yoast_head":"\nGluten Peptides Resistant to Digestion: Intestinal Barrier, Innate Immunity and Microbiota - Glutenlight<\/title>\n<meta name=\"description\" content=\"Analysis of the interactions between gluten peptides resistant to digestion, intestinal barrier integrity, innate immunity and microbiota in conditions of mucosal vulnerability.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/glutenlight.eu\/?p=13203&lang=en\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gluten Peptides Resistant to Digestion: Intestinal Barrier, Innate Immunity and Microbiota - Glutenlight\" \/>\n<meta property=\"og:description\" content=\"Analysis of the interactions between gluten peptides resistant to digestion, intestinal barrier integrity, innate immunity and microbiota in conditions of mucosal vulnerability.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/glutenlight.eu\/?p=13203&lang=en\" \/>\n<meta property=\"og:site_name\" content=\"Glutenlight\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-24T01:55:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-24T01:56:18+00:00\" \/>\n<meta name=\"author\" content=\"luciano\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"luciano\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"16 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/glutenlight.eu\/?p=13203&lang=en#article\",\"isPartOf\":{\"@id\":\"https:\/\/glutenlight.eu\/?p=13203&lang=en\"},\"author\":{\"name\":\"luciano\",\"@id\":\"https:\/\/glutenlight.eu\/#\/schema\/person\/ce85ed8d5ff511199b9e80b95af8990d\"},\"headline\":\"Gluten peptides relatively resistant to digestion: interactions with the intestinal barrier, innate immunity, and mucosal vulnerability\",\"datePublished\":\"2026-03-24T01:55:13+00:00\",\"dateModified\":\"2026-03-24T01:56:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/glutenlight.eu\/?p=13203&lang=en\"},\"wordCount\":2868,\"publisher\":{\"@id\":\"https:\/\/glutenlight.eu\/#organization\"},\"keywords\":[\"breadmaking and protein digestion\",\"CXCR3 MyD88 zonulin pathway\",\"dough fermentation and gluten digestion\",\"food peptides and innate immunity\",\"gliadin p31-43 inflammasome activation\",\"gliadin peptide p31-43\",\"gluten biochemistry\",\"gluten intestinal permeability\",\"gluten microbiota interaction\",\"gluten peptides resistant to digestion\",\"gut brain axis inflammation\",\"incomplete gluten digestion\",\"intestinal barrier and gluten\",\"intestinal dysbiosis and gluten\",\"intestinal innate immunity\",\"intestinal mucosal barrier\",\"intestinal mucosal vulnerability\",\"intestinal NLRP3 inflammasome\",\"intestinal permeability and inflammation\",\"intestinal protein digestion\",\"intestinal tight junctions\",\"low-grade intestinal inflammation\",\"microbiota and gluten\",\"microbiota and protein digestion\",\"mucosal immune activation\",\"mucosal immune response\",\"natural fermentation and peptide degradation\",\"nutritional intestinal immunology\",\"wheat protein matrix\",\"zonulin and gluten\"],\"articleSection\":[\"Article\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/glutenlight.eu\/?p=13203&lang=en\",\"url\":\"https:\/\/glutenlight.eu\/?p=13203&lang=en\",\"name\":\"Gluten Peptides Resistant to Digestion: Intestinal Barrier, Innate Immunity and Microbiota - Glutenlight\",\"isPartOf\":{\"@id\":\"https:\/\/glutenlight.eu\/#website\"},\"datePublished\":\"2026-03-24T01:55:13+00:00\",\"dateModified\":\"2026-03-24T01:56:18+00:00\",\"description\":\"Analysis of the interactions between gluten peptides resistant to digestion, intestinal barrier integrity, innate immunity and microbiota in conditions of mucosal vulnerability.\",\"breadcrumb\":{\"@id\":\"https:\/\/glutenlight.eu\/?p=13203&lang=en#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/glutenlight.eu\/?p=13203&lang=en\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/glutenlight.eu\/?p=13203&lang=en#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/glutenlight.eu\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gluten peptides relatively resistant to digestion: interactions with the intestinal barrier, innate immunity, and mucosal vulnerability\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/glutenlight.eu\/#website\",\"url\":\"https:\/\/glutenlight.eu\/\",\"name\":\"Glutenlight\",\"description\":\"grani con glutine leggero e tollerabile\",\"publisher\":{\"@id\":\"https:\/\/glutenlight.eu\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/glutenlight.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/glutenlight.eu\/#organization\",\"name\":\"Gluten Light\",\"url\":\"https:\/\/glutenlight.eu\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/glutenlight.eu\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/glutenlight.eu\/wp-content\/uploads\/2026\/01\/Logo-di-Gluten-Light-con-simbolo-solare.jpg\",\"contentUrl\":\"https:\/\/glutenlight.eu\/wp-content\/uploads\/2026\/01\/Logo-di-Gluten-Light-con-simbolo-solare.jpg\",\"width\":1113,\"height\":648,\"caption\":\"Gluten Light\"},\"image\":{\"@id\":\"https:\/\/glutenlight.eu\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/glutenlight.eu\/#\/schema\/person\/ce85ed8d5ff511199b9e80b95af8990d\",\"name\":\"luciano\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/glutenlight.eu\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/32520888e50495c97b3dcb1eb9761e897db01ea203f0c45a441dc878d64c05b1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/32520888e50495c97b3dcb1eb9761e897db01ea203f0c45a441dc878d64c05b1?s=96&d=mm&r=g\",\"caption\":\"luciano\"},\"url\":\"https:\/\/glutenlight.eu\/?author=2\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gluten Peptides Resistant to Digestion: Intestinal Barrier, Innate Immunity and Microbiota - Glutenlight","description":"Analysis of the interactions between gluten peptides resistant to digestion, intestinal barrier integrity, innate immunity and microbiota in conditions of mucosal vulnerability.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/glutenlight.eu\/?p=13203&lang=en","og_locale":"it_IT","og_type":"article","og_title":"Gluten Peptides Resistant to Digestion: Intestinal Barrier, Innate Immunity and Microbiota - Glutenlight","og_description":"Analysis of the interactions between gluten peptides resistant to digestion, intestinal barrier integrity, innate immunity and microbiota in conditions of mucosal vulnerability.","og_url":"https:\/\/glutenlight.eu\/?p=13203&lang=en","og_site_name":"Glutenlight","article_published_time":"2026-03-24T01:55:13+00:00","article_modified_time":"2026-03-24T01:56:18+00:00","author":"luciano","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"luciano","Tempo di lettura stimato":"16 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/glutenlight.eu\/?p=13203&lang=en#article","isPartOf":{"@id":"https:\/\/glutenlight.eu\/?p=13203&lang=en"},"author":{"name":"luciano","@id":"https:\/\/glutenlight.eu\/#\/schema\/person\/ce85ed8d5ff511199b9e80b95af8990d"},"headline":"Gluten peptides relatively resistant to digestion: interactions with the intestinal barrier, innate immunity, and mucosal vulnerability","datePublished":"2026-03-24T01:55:13+00:00","dateModified":"2026-03-24T01:56:18+00:00","mainEntityOfPage":{"@id":"https:\/\/glutenlight.eu\/?p=13203&lang=en"},"wordCount":2868,"publisher":{"@id":"https:\/\/glutenlight.eu\/#organization"},"keywords":["breadmaking and protein digestion","CXCR3 MyD88 zonulin pathway","dough fermentation and gluten digestion","food peptides and innate immunity","gliadin p31-43 inflammasome activation","gliadin peptide p31-43","gluten biochemistry","gluten intestinal permeability","gluten microbiota interaction","gluten peptides resistant to digestion","gut brain axis inflammation","incomplete gluten digestion","intestinal barrier and gluten","intestinal dysbiosis and gluten","intestinal innate immunity","intestinal mucosal barrier","intestinal mucosal vulnerability","intestinal NLRP3 inflammasome","intestinal permeability and inflammation","intestinal protein digestion","intestinal tight junctions","low-grade intestinal inflammation","microbiota and gluten","microbiota and protein digestion","mucosal immune activation","mucosal immune response","natural fermentation and peptide degradation","nutritional intestinal immunology","wheat protein matrix","zonulin and gluten"],"articleSection":["Article"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/glutenlight.eu\/?p=13203&lang=en","url":"https:\/\/glutenlight.eu\/?p=13203&lang=en","name":"Gluten Peptides Resistant to Digestion: Intestinal Barrier, Innate Immunity and Microbiota - Glutenlight","isPartOf":{"@id":"https:\/\/glutenlight.eu\/#website"},"datePublished":"2026-03-24T01:55:13+00:00","dateModified":"2026-03-24T01:56:18+00:00","description":"Analysis of the interactions between gluten peptides resistant to digestion, intestinal barrier integrity, innate immunity and microbiota in conditions of mucosal vulnerability.","breadcrumb":{"@id":"https:\/\/glutenlight.eu\/?p=13203&lang=en#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/glutenlight.eu\/?p=13203&lang=en"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/glutenlight.eu\/?p=13203&lang=en#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/glutenlight.eu\/"},{"@type":"ListItem","position":2,"name":"Gluten peptides relatively resistant to digestion: interactions with the intestinal barrier, innate immunity, and mucosal vulnerability"}]},{"@type":"WebSite","@id":"https:\/\/glutenlight.eu\/#website","url":"https:\/\/glutenlight.eu\/","name":"Glutenlight","description":"grani con glutine leggero e tollerabile","publisher":{"@id":"https:\/\/glutenlight.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/glutenlight.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/glutenlight.eu\/#organization","name":"Gluten Light","url":"https:\/\/glutenlight.eu\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/glutenlight.eu\/#\/schema\/logo\/image\/","url":"https:\/\/glutenlight.eu\/wp-content\/uploads\/2026\/01\/Logo-di-Gluten-Light-con-simbolo-solare.jpg","contentUrl":"https:\/\/glutenlight.eu\/wp-content\/uploads\/2026\/01\/Logo-di-Gluten-Light-con-simbolo-solare.jpg","width":1113,"height":648,"caption":"Gluten Light"},"image":{"@id":"https:\/\/glutenlight.eu\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/glutenlight.eu\/#\/schema\/person\/ce85ed8d5ff511199b9e80b95af8990d","name":"luciano","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/glutenlight.eu\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/32520888e50495c97b3dcb1eb9761e897db01ea203f0c45a441dc878d64c05b1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/32520888e50495c97b3dcb1eb9761e897db01ea203f0c45a441dc878d64c05b1?s=96&d=mm&r=g","caption":"luciano"},"url":"https:\/\/glutenlight.eu\/?author=2"}]}},"_links":{"self":[{"href":"https:\/\/glutenlight.eu\/index.php?rest_route=\/wp\/v2\/posts\/13203","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/glutenlight.eu\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/glutenlight.eu\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/glutenlight.eu\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/glutenlight.eu\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13203"}],"version-history":[{"count":2,"href":"https:\/\/glutenlight.eu\/index.php?rest_route=\/wp\/v2\/posts\/13203\/revisions"}],"predecessor-version":[{"id":13205,"href":"https:\/\/glutenlight.eu\/index.php?rest_route=\/wp\/v2\/posts\/13203\/revisions\/13205"}],"wp:attachment":[{"href":"https:\/\/glutenlight.eu\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13203"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/glutenlight.eu\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13203"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/glutenlight.eu\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}